White Paper ► Retain Control, Retain Revenue

Amid regulatory uncertainty and ongoing financial pressure, some hospitals and health systems are entertaining offers to sell ambulatory laboratory operations, with sale prices that look like a financial windfall.

Before health systems consider selling ambulatory lab operations, they need to understand the big picture of how labs influence the financial health of the system. When laboratory operations are sold, health systems lose a robust contributor to the bottom line.

Recognize and Elevate Your Lab's Revenue Potential

This white paper explores the clinical lab's financial contribution to the health system and examines the benefits of growing ambulatory services, rather than selling them to a third party. In the white paper, you'll discover:

• How financial pressure is leading health systems to consider selling ambulatory lab operations
• Why ambulatory lab operations are a financial contributor, not a cost center
• The potential negative financial impacts of selling ambulatory lab operations
• Benefits beyond the bottom line of expanding ambulatory testing operations
• Real-world success stories of system laboratories that have invested in expanding ambulatory lab services